GlassScriptPhysician profile
Edris Alderwish
NPI 1285959858
$81,465.41
in general payments reported to CMS, 2019-2025
35 companies · $35K in 2025
The $35K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,036 · 2020: $3,995 · 2021: $1,511 · 2022: $536 · 2023: $4,230 · 2024: $32K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20K · Consulting Fee: $20K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,200 · Travel and Lodging: $6,421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20,365.39 |
| Consulting Fee | $20,350.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $17,050.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,200.00 |
| Travel and Lodging | $6,421.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $45,606.60 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $15,481.39 | 2019-2025 | Indigo System, Penumbra System |
| Abiomed | $6,775.97 | 2019-2025 | Impella |
| Boston Scientific Corporation | $3,009.88 | 2019-2025 | General - Therapies, Sentinel, Emblem Mri S-Icd |
| Cardiovascular Systems INC. | $1,939.13 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,317.98 | 2019-2025 | Lifevest |
| Philips North America LLC | $1,181.64 | 2019-2025 | (5044) Mcot, Coronary Other, IV Other |
| Medtronic Vascular, INC. | $1,139.46 | 2019-2020 | |
| Abbott Laboratories | $1,050.75 | 2019-2024 | Pressurewire, Absolute Pro, Diamondback Coronary |
| Novartis Pharmaceuticals Corporation | $835.94 | 2021-2025 | |
| Medtronic, INC. | $537.30 | 2021-2024 | Micra, Symplicity G3 |
| Edwards Lifesciences Corporation | $425.01 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Amgen INC. | $331.30 | 2019-2024 | Repatha |
| Novo Nordisk INC | $271.63 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $231.95 | 2019-2024 | Brilinta, Farxiga, Wainua |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edris Alderwish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.